Revision as of 19:25, 27 March 2020 editBoghog (talk | contribs)Autopatrolled, Extended confirmed users, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers, Template editors137,965 edits consistent citation formatting← Previous edit | Latest revision as of 13:49, 30 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers174,388 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper | ||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} | |||
{{Drugbox | {{Drugbox | ||
| verifiedrevid = 464210016 | | verifiedrevid = 464210016 | ||
Line 4: | Line 5: | ||
| image = Polynoxylin skeletal.svg | | image = Polynoxylin skeletal.svg | ||
<!--Clinical data --> | <!--Clinical data --> | ||
| tradename = |
| tradename = | ||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | ||
| pregnancy_US = <!-- A / B / C / D / X --> | | pregnancy_US = <!-- A / B / C / D / X --> | ||
| pregnancy_category = |
| pregnancy_category = | ||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | ||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | ||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | ||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| legal_status = |
| legal_status = | ||
| routes_of_administration = Topical | | routes_of_administration = Topical | ||
<!--Pharmacokinetic data --> | <!--Pharmacokinetic data --> | ||
| bioavailability = |
| bioavailability = | ||
| protein_bound = |
| protein_bound = | ||
| metabolism = |
| metabolism = | ||
| elimination_half-life = |
| elimination_half-life = | ||
| excretion = |
| excretion = | ||
<!--Identifiers --> | <!--Identifiers --> | ||
| CAS_number_Ref = {{cascite|correct|??}} | | CAS_number_Ref = {{cascite|correct|??}} | ||
Line 25: | Line 26: | ||
| ATC_prefix = A01 | | ATC_prefix = A01 | ||
| ATC_suffix = AB05 | | ATC_suffix = AB05 | ||
| ATC_supplemental = |
| ATC_supplemental = {{ATC|D01|AE05}} | ||
| PubChem = |
| PubChem = | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
| DrugBank = |
| DrugBank = | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = none | | ChemSpiderID = none | ||
| KEGG = D07067 | |||
| UNII = E18NBG5EEY | |||
<!--Chemical data --> | <!--Chemical data --> | ||
| chemical_formula = (C<sub>4</sub>H<sub>8</sub>N<sub>2</sub>O<sub>3</sub>)<sub>n</sub> | | chemical_formula = (C<sub>4</sub>H<sub>8</sub>N<sub>2</sub>O<sub>3</sub>)<sub>n</sub> | ||
Line 36: | Line 39: | ||
}} | }} | ||
'''Polynoxylin''' (trade name '''Anaflex''') is an ] for local treatment of the skin and the ]. It is a ] ] ].<ref>{{cite journal | vauthors = Kingston D | title = Release of formaldehyde from polynoxylin and noxythiolin | journal = Journal of Clinical Pathology | volume = 18 | issue = 5 | pages = 666–7 | date = September 1965 | pmid = 5835451 | pmc = 473043 | doi = 10.1136/jcp.18.5.666 }}</ref> | '''Polynoxylin''' (trade name '''Anaflex''' in Egypt<ref>{{drugs.com|international|anaflex-10}}: Anaflex 10%. Accessed 2020-08-01.</ref>) is an ] for local treatment of the skin and the ]. It is a ] ] ].<ref>{{cite journal | vauthors = Kingston D | title = Release of formaldehyde from polynoxylin and noxythiolin | journal = Journal of Clinical Pathology | volume = 18 | issue = 5 | pages = 666–7 | date = September 1965 | pmid = 5835451 | pmc = 473043 | doi = 10.1136/jcp.18.5.666 }}</ref> | ||
== References == | == References == | ||
Line 47: | Line 50: | ||
] | ] | ||
{{ |
{{gastrointestinal-drug-stub}} | ||
{{dermatologic-drug-stub}} |
Latest revision as of 13:49, 30 January 2023
Chemical compound Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Topical |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.108.096 |
Chemical and physical data | |
Formula | (C4H8N2O3)n |
(verify) |
Polynoxylin (trade name Anaflex in Egypt) is an antiseptic for local treatment of the skin and the mouth. It is a formaldehyde releasing antimicrobial polymer.
References
- International Drug Names: Anaflex 10%. Accessed 2020-08-01.
- Kingston D (September 1965). "Release of formaldehyde from polynoxylin and noxythiolin". Journal of Clinical Pathology. 18 (5): 666–7. doi:10.1136/jcp.18.5.666. PMC 473043. PMID 5835451.
This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |
This dermatologic drug article is a stub. You can help Misplaced Pages by expanding it. |